Goldman criteria classification of 41 missed infectious diseases first detected on autopsy in 185 HCT recipients between 1 January 2000 and 31 December 2017
| Goldman criteria classification . | n (%) . |
|---|---|
| Class I: missed major diagnoses for which detection before death would in all probability have led to a change in management that might have resulted in cure or prolonged survival | 31 (75.6) |
| Fungal | 14 (34.2) |
| Candida | 4 (9.8) |
| Aspergillus | 4 (9.8) |
| Mucorales | 4 (9.8) |
| Scedosporium | 1 (2.4) |
| Coccidioides | 1 (2.4) |
| Viral | 12 (29.3) |
| CMV | 4 (9.8) |
| Adenovirus | 4 (9.8) |
| HSV | 2 (4.9) |
| VZV | 1 (2.4) |
| RSV | 1 (2.4) |
| Bacterial | 3 (7.3) |
| Enterococcus | 2 (4.9) |
| S aureus | 1 (2.4) |
| Parasitic | 2 (4.9) |
| S stercoralis | 1 (2.4) |
| T gondii | 1 (2.4) |
| Class II: missed major diagnoses for which detection before death would probably not have led to a change in management | 5 (12.2) |
| Viral | 2 (4.9) |
| CMV | 2 (4.9) |
| Bacterial | 2 (4.9) |
| Gram-positive coccus | 1 (2.4) |
| Gram-negative bacillus | 1 (2.4) |
| Fungal | 1 (2.4) |
| Aspergillus | 1 (2.4) |
| Class III: missed minor diagnoses related to the terminal disease process but not directly related to death | 1 (2.4) |
| Fungal | 1 (2.4) |
| Candida | 1 (2.4) |
| Class IV: either important unrelated diagnoses that might eventually have affected prognosis or processes that contributed to death in a terminally ill patient | 4 (9.8) |
| Viral | 4 (9.8) |
| BK virus | 4 (9.8) |
| Goldman criteria classification . | n (%) . |
|---|---|
| Class I: missed major diagnoses for which detection before death would in all probability have led to a change in management that might have resulted in cure or prolonged survival | 31 (75.6) |
| Fungal | 14 (34.2) |
| Candida | 4 (9.8) |
| Aspergillus | 4 (9.8) |
| Mucorales | 4 (9.8) |
| Scedosporium | 1 (2.4) |
| Coccidioides | 1 (2.4) |
| Viral | 12 (29.3) |
| CMV | 4 (9.8) |
| Adenovirus | 4 (9.8) |
| HSV | 2 (4.9) |
| VZV | 1 (2.4) |
| RSV | 1 (2.4) |
| Bacterial | 3 (7.3) |
| Enterococcus | 2 (4.9) |
| S aureus | 1 (2.4) |
| Parasitic | 2 (4.9) |
| S stercoralis | 1 (2.4) |
| T gondii | 1 (2.4) |
| Class II: missed major diagnoses for which detection before death would probably not have led to a change in management | 5 (12.2) |
| Viral | 2 (4.9) |
| CMV | 2 (4.9) |
| Bacterial | 2 (4.9) |
| Gram-positive coccus | 1 (2.4) |
| Gram-negative bacillus | 1 (2.4) |
| Fungal | 1 (2.4) |
| Aspergillus | 1 (2.4) |
| Class III: missed minor diagnoses related to the terminal disease process but not directly related to death | 1 (2.4) |
| Fungal | 1 (2.4) |
| Candida | 1 (2.4) |
| Class IV: either important unrelated diagnoses that might eventually have affected prognosis or processes that contributed to death in a terminally ill patient | 4 (9.8) |
| Viral | 4 (9.8) |
| BK virus | 4 (9.8) |